Skip to content
Screener

OraSure Technologies OSUR HIV — Net revenues

Other product segments

Sample Management Solutions
$9.88M+0.2%
HCV
$3.39M-17.8%
Other Product And Services Revenues
$2.29M+130%
Other
$915K—
COVID-19
$1K-96.4%
Risk Assessment Testing
$0-100%

Similar metrics at other companies

ROP
ROPProduct Revenue — Net revenues
$462.7M+7.7%
Travel + Leisure logo
TNLDeferred subscription revenue — Net revenues
$42M-2.3%
ROP
ROPTotal Software Revenue — Net revenues
$1.63B+12.4%
Travel + Leisure logo
TNLDeferred exchange-related revenue — Net revenues
$9M0.0%
Gen Digital Inc. logo
GENSubscription and service revenue — Net revenues
$1.33B+6.2%
Travel + Leisure logo
TNLAncillary revenues — Net revenues
$0-100%

Other financials

Income statement

See full
Revenue$30.6M-1.9%
Gross profit$13.3M+1.2%
Operating income$5.4M+130%
Net income$6.2M+132%
EPS (diluted)$0.09+135%

Balance sheet

See full
Cash & equivalents$160.6M-31.5%
Total debt$12.1M-14.4%
Total equity$317.8M-16.5%
Total assets$360.6M-19.0%

Cash flow

See full
Operating cash flow-$9.9M+3.0%
CapEx$2.4M+25.4%
Free cash flow-$12.3M-1.6%

Valuation

See full
Market cap$275.87M+35.2%
Enterprise value$127.39M-877%
P/S2.5×+1.0×

Profitability

See full
Gross margin42.6%+2.1pp
Operating margin-48.1%+14.2pp
Net margin-43.7%+10.0pp
FCF margin-42.8%-85.7pp

Returns & leverage

See full
Return on equity-14.1%+1.8pp
Debt / equity0×0.0×
Current ratio8.9×+1.8×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: OraSure Technologies’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001116463-26-000052
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
NET REVENUES:
Products and services$29,724$29,847$56,100$58,844
Other9151,3952,4642,329
30,63931,24258,56461,173
COST OF PRODUCTS AND SERVICES SOLD17,32218,08333,44335,715
Gross profit13,31713,15925,12125,458
OPERATING EXPENSES:
Research and development9,43711,40123,09121,004

Item 1. FINANCIAL STATEMENTS

FAQ

What is OraSure Technologies's HIV — net revenues?
OraSure Technologies (OSUR) reported HIV — net revenues of $14.17M in Q2 2026.
How has OraSure Technologies's HIV — net revenues changed year-over-year?
OraSure Technologies's HIV — net revenues decreased by 1.6% year-over-year, from $14.4M to $14.17M.
What is the long-term trend for OraSure Technologies's HIV — net revenues?
Over 4 years (2021 to 2025), OraSure Technologies's HIV — net revenues has grown at a 4.3% compound annual growth rate (CAGR), from $42.14M to $49.8M.
What does HIV — net revenues mean?
This metric represents the total gross sales generated from the sale of diagnostic tests and specimen collection devices specifically designed for the detection of HIV. It serves as a key indicator of the company's market penetration and demand within the infectious disease diagnostics sector. Monitoring these revenues helps investors assess the commercial performance and growth trajectory of the company's specialized HIV-related product portfolio.

Ask your AI about OraSure Technologies's hiv — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude